Tak 2006.
Study characteristics | ||
Methods | RCT. 6 arms. | |
Participants | Number of children: 20 control, 20 treatment Sex of children: 25 M, 15 F Age range of children: 3 ‐ 12 years Mean age of children: 6.6 ± 2.9 years (intervention); 6.6 ± 2.7 years (control) Needle procedure: venepuncture Diagnosis: none reported Inclusion criteria: Dutch children receiving a venepuncture Exclusion criteria: children of non‐Dutch parentage Setting: outpatient centre of the St Antonius Ziekenhuis in Nieuwegein (the Netherlands) |
|
Interventions | Definitions for the following condition components are provided below. 1. Placebo, distraction, information 2. EMLA, distraction, information 3. Placebo, information 4. EMLA, information 5. Information 6. Non‐treatment control Distraction: During the venepuncture, a funny 6‐minute fragment of a video cartoon (Walk Disney's 'Beauty and the Beast') was shown. Sound could be heard through a headphone. Procedural Information: All children except those in the control groups received information on the venepuncture by means of a photo book. The supervising research assistant asked the child to read the book with his/her parent(s) while in the waiting room. The 24 photos, each accompanied by a short and simple text, showed step‐by‐step what was to come from entrance to departure from the hospital. A boy 8 years old acted as the model. EMLA: EMLA cream was applied by the laboratory personnel on duty who did not know whether the cream was EMLA or a placebo cream. These were not necessarily the same persons as those who did the pricking. Placebo: A placebo cream was applied by the laboratory personnel on duty who did not know whether the cream was EMLA or a placebo cream. These were not necessarily the same persons as those who did the pricking. *Because EMLA requires 1 hour to produce its effect, the children in the4 ‘cream conditions’ passed that time in the waiting room in the presence of their parent(s). Non‐treatment control: no treatment provided |
|
Outcomes | Pain measure:
Distress measure:
Adverse events: none mentioned |
|
Notes | We used a total N of 94 for this study (instead of 136) because we only included 4 of 6 conditions (i.e. placebo, distraction, information versus placebo, information and information versus non‐treatment control). Although GDS ratings were calculated at 3 time points in this study (child entering the room, just before venepuncture, and during venepuncture), we only used the 'during venepuncture' scores in the analyses for this review. Study dates: September 1993 to February 1995 Funding: none stated Conflicts of interest: none declared |
|
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Unclear risk | Randomized ‐ no further details. Insufficient information to permit judgment of 'low' or 'high' risk |
Allocation concealment (selection bias) | Unclear risk | Insufficient information to permit judgment of 'low' or 'high' risk |
Blinding of participants and personnel (performance bias) All outcomes | High risk | Participants and personnel were not blinded |
Blinding of outcome assessment (detection bias) All outcomes | High risk | No blinding of outcome assessment |
Incomplete outcome data (attrition bias) All outcomes | Unclear risk | No reasons for missing data provided |
Selective reporting (reporting bias) | Unclear risk | Insufficient information to permit judgment of 'low' or 'high' risk |
Other bias | Unclear risk | Insufficient information to assess whether an important risk of bias exists |